SCHEMBL6236235

SCHEMBL6236235

COc1ccc(NN2C(=O)c3[nH]c4cc(Cl)ccc4c(=O)c3C2=O)c(C)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.39
CA9 Q16790 1/20 0.39
TP53 P04637 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
S1PR4 O95977 1/20 0.37
PIM1 P11309 3/20 0.37
CLK4 Q9HAZ1 2/20 0.37
AXL P30530 1/20 0.37
PTK2B Q14289 1/20 0.37
MAPKAPK5 Q8IW41 1/20 0.37
SRPK1 Q96SB4 1/20 0.37
MAPK13 O15264 1/20 0.37
MAPK12 P53778 1/20 0.37
MAPK11 Q15759 1/20 0.37
MAPK14 Q16539 1/20 0.37
CYP19A1 P11511 2/20 0.36
CDK4 P11802 2/20 0.36
CCND1 P24385 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6233199 0.88 CYP19A1 (0.42) CA9PIM1CLK4AXLPTK2B
SCHEMBL6233754 0.86 MAPK13 (0.40) CA9MAPK13MAPK12MAPK11MAPK14
SCHEMBL6231824 0.82 TUBB4A (0.42) CA9PIM1CLK4CDK4CCND1
SCHEMBL6232252 0.80 LMNA (0.42) CA9TP53SMN1; SMN2PIM1CLK4
SCHEMBL6231910 0.79 PIM1 (0.44) KDM4ECA9TP53SMN1; SMN2PIM1
SCHEMBL6239738 0.77 CA1 (0.50) S1PR4PIM1CLK4AXLPTK2B
SCHEMBL6231904 0.77 CA1 (0.41) CA9TP53SMN1; SMN2PIM1CLK4
SCHEMBL6231125 0.76 PIM1 (0.47) CA9TP53SMN1; SMN2PIM1CLK4
SCHEMBL6233755 0.76 PIM1 (0.40) CA9TP53SMN1; SMN2PIM1CLK4
SCHEMBL6232338 0.76 CA1 (0.44) PIM1CLK4AXLPTK2BMAPKAPK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1004582-B1 Pyridazino quinoline compounds ASTRAZENECA AB (SE) 2005-05-18 EP disclosed
EP-0790996-B1 PYRIDAZINOQUINOLINE COMPOUNDS ASTRAZENECA AB (SE) 2002-03-27 EP disclosed
US-6232313-B1 TREATING STROKE OR EPILEPTIC CONVULSIONS ASSOCIATED WITH EXCESSIVE CALCIUM INFLUX IN THE BRAIN CAUSED BY EXCITATORY AMINO ACIDS ZENECA LIMITED (GB) 2001-05-15 US disclosed
US-6214826-B1 NERVOUS SYSTEM DISORDERS ZENECA LIMITED (GB) 2001-04-10 US disclosed
EP-0724583-B1 PYRIDAZINO QUINOLINE COMPOUNDS ASTRAZENECA AB (SE) 2000-12-13 EP disclosed
EP-1004582-A2 Pyridazino quinoline compounds AstraZeneca UK Limited (GB) 2000-05-31 EP disclosed
US-5744471-A NERVOUS SYSTEM DISORDERS ZENECA LIMITED (GB) 1998-04-28 US disclosed
EP-0790996-A1 PYRIDAZINOQUINOLINE COMPOUNDS ZENECA LIMITED (GB) 1997-08-27 EP disclosed
EP-0724583-A1 PYRIDAZINO QUINOLINE COMPOUNDS ZENECA LIMITED (GB) 1996-08-07 EP disclosed
WO-1996015127-A1 PYRIDAZINOQUINOLINE COMPOUNDS ZENECA LIMITED (GB) 1996-05-23 WO disclosed
WO-1995011244-A1 PYRIDAZINO QUINOLINE COMPOUNDS ZENECA LIMITED (GB) 1995-04-27 WO disclosed